The impact of oral anticoagulants on idiopathic pulmonary fibrosis risk and prognosis: a population study

Affiliations

• ¹ Respiratory Unit, Department of Biomedical Sciences and Public Health, Polytechnic University of Marche, Ancona, Italy f.gonnelli@pm.univpm.it.
• ² Translational Medical Sciences, University of Nottingham, Nottingham, UK.
• ³ Optimum Patient Care Global, Cambridge, UK.
• ⁴ Observational and Pragmatic Research Institute Pte Ltd, Singapore, Singapore.
• ⁵ Department of Respiratory Medicine, Sir Charles Gardiner Hospital, Perth, Australia.
• ⁶ School of Medicine, University of Queensland, Brisbane, Australia.
• ⁷ Centre for Respiratory Research, University of Western Australia, Perth, Australia.
• ⁸ Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Sydney, Australia.
• ⁹ Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
• ¹⁰ Respiratory Unit, Department of Biomedical Sciences and Public Health, Polytechnic University of Marche, Ancona, Italy.
• ¹¹ Respiratory Unit, Department of Internal Medicine, "Azienda Ospedaliero-Universitaria delle Marche", Ancona, Italy.
• ¹² Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
• ¹³ NHMRC Centre of Research Excellence in Pulmonary Fibrosis, Sydney, Australia.